التفاصيل البيبلوغرافية
| العنوان: |
In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer. |
| المؤلفون: |
Saidi, Samir A., Holland, Cathrine M., Charnock-Jones, D. Stephen, Smith, Stephen K. |
| المصدر: |
Molecular Cancer; 2006, Vol. 5, p13-14, 14p, 1 Chart, 6 Graphs |
| مصطلحات موضوعية: |
ENDOMETRIAL cancer, APOPTOSIS, TUMOR growth, FENOFIBRATE, CANCER research, TRETINOIN, THERAPEUTICS |
| مستخلص: |
: Fenofibrate, an agonist of PPAR-alpha, in doses above 25 μM, inhibits proliferation and induces apoptosis in Ishikawa endometrial cancer cells. We show that these effects are potentiated by retinoic acid, an agonist of the retinoid-X-receptor. DNA content analysis shows that G1/S phase progression through the cell cycle is inhibited. Independent Component Analysis of gene microarray experiments demonstrated downregulation of Cyclin D1 (CCND1) and associated changes in cell cycle gene expression. Expression of PPAR-alpha mRNA was reduced by >75% using RNA-interference but this resulted in only minor changes in biological effects. A nude mouse model of endometrial carcinoma was used to investigate the effect of fenofibrate in vivo but failed to show consistent inhibition of tumour growth. Conclusion: The combination of fenofibrate and retinoic acid is a potent inhibitor of Ishikawa endometrial cancer cell growth in vitro. [ABSTRACT FROM AUTHOR] |
|
Copyright of Molecular Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder